Knight-Owl
Knight-Owl
Sex: M
Data Quality: 0 stars
MS: 13 yrs
Type: Secondary Progressive
Sensation: Moderate
Overall: Mild
Cognition: mild
Vision: none
Speech: mild
Swallowing: mild
Upper limb: moderate
Walking: severe
Knight-Owl
Male, 41 years
Bay Area, CA
Primary Condition
MS
Type
Secondary Progressive
First symptom
11/98
Diagnosis
03/99
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

Knight-Owl's Glatiramer acetate is for:

  • MS

Knight-Owl has not reported any side effects for Glatiramer acetate.

Knight-Owl's Glatiramer acetate History (Stopped)
20 mg Daily Jun 01, 2004 - Mar 01, 2007
Stopped Did not seem to work Mar 01, 2007
Evaluations
Date Dosage MS (Multiple Sclerosis) Efficacy Side Effects Adherence Burden
Mar 01, 2007 20 mg Daily Led_efficacy_2Led_efficacy_2Led_defaultLed_default NoneNoneNoneNone AlwaysAlwaysAlwaysAlways A littleA littleA littleA little
Date
Mar 01, 2007
Advice & Tips
Daily injections lead to a toughening of the sub-dermal layer and an ever shrinking area in which to inject. I never had much fat and had to be creative until I decided it was less effective than Avonex. However I tried Novantrone next; A fast failure.
Cost: $25-49 monthly

About Glatiramer acetate (Prescription Drug)

Glatiramer acetate combines four amino acids including L-alanine, L-glutamic acid, L-lysine and L-tyrosine. It is used for Relapsing-Remitting Multiple Sclerosis (RRMS) to reduce the frequency and severity of relapses. It is administered as a subcutaneous injection.

Learn more about Glatiramer acetate in our Glatiramer acetate Community Report.